Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics.

Güler, Halil Ibrahim; Ay Sal, Fulya; Can, Zehra; Kara, Yakup; Yildiz, Oktay; Beldüz, Ali Osman; Çanakçi, Sabriye; Kolayli, Sevgi

Güler, Halil Ibrahim; Ay Sal, Fulya; Can, Zehra; Kara, Yakup; Yildiz, Oktay; Beldüz, Ali Osman; Çanakçi, Sabriye; Kolayli, Sevgi.

Afiliação

Güler HI; Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.
Ay Sal F; Department of Biology, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.
Can Z; School of Applied Sciences, Bayburt University, Bayburt Turkey.
Kara Y; Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.
Yildiz O; Department of Biochemistry, Faculty of Pharmacy, Basic Pharmaceutical Sciences, Karadeniz Technical University, Trabzon Turkey.
Beldüz AO; Department of Biology, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.
Çanakçi S; Department of Biology, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.
Kolayli S; Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon Turkey.

Turk J Biol ; 45(4): 530-548, 2021.

Article em En | MEDLINE | ID: mdl-34803452

Palavras-chave

Covid-19; Propolis; SARS-CoV-2; molecular docking; pinocembrin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Turk J Biol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google